DNA-RNAサンプル調製市場：タイプ、用途、エンドユーザー別-2025-2030年の世界予測

DNA-RNAサンプル調製市場は、2023年に20億5,000万米ドルと評価され、2024年には22億2,000万米ドルに達すると予測され、CAGR 8.52%で成長し、2030年には36億4,000万米ドルになると予測されています。

DNA-RNAサンプル調製は、分子生物学および遺伝子分析に不可欠な要素であり、診断、治療薬開発、法医学分析など様々な用途に必要な基礎資料を提供します。効率的で正確なサンプル調製の必要性は、疾患検出、遺伝子研究、個別化医療などの分野で信頼性の高いデータが緊急に必要とされていることからも明らかです。応用範囲は広く、学術研究、臨床診断、バイオテクノロジー、製薬開発に及ぶ。主なエンドユーザーには、研究所、診断センター、バイオテクノロジー企業が含まれます。この市場は、サンプル調製技術の技術的進歩、遺伝子研究への投資の増加、高度な調査手法が必要とされる遺伝子疾患の有病率の上昇によって大きな影響を受けています。自動サンプル調製システムやハイスループット・サンプル調製システムなどの技術革新は、エラー発生率の低減や処理速度の向上により、大きなビジネスチャンスをもたらしています。ゲノム研究イニシアチブの成長は市場拡大をさらに後押しします。しかし、高度な前処理キットに関連する高コスト、厳しい規制要件、専門スキルの必要性などの課題は、成長の妨げとなる可能性があります。また、サンプルの品質にばらつきがあり、これが下流の分析に影響を及ぼす可能性もあることから、限界も生じています。これらのハードルを克服するために、企業は高いサンプルの完全性と信頼性を維持する、費用対効果の高い簡素化されたプロトコルの開発に注力すべきです。技術革新が必要な分野には、サンプル調製システムの小型化、データ管理のためのデジタルツールとの統合、さまざまなサンプルタイプに対応できるユニバーサルキットの開発などがあります。市場は依然としてダイナミックであり、急速な技術進歩と競争の激化を特徴としています。企業は、市場の複雑さを効果的に乗り切るために、技術革新、戦略的パートナーシップ、規制当局との連携に重点を置き、機敏に対応する必要があります。個別化医療と遠隔医療の成長動向に合わせて製品開発を行うことで、企業は新たな機会を捉え、この進化する業界で成長を維持することができます。

市場力学：急速に進化するDNA-RNAサンプル調製市場の主要市場インサイトを公開

DNA-RNAサンプル調製市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 分子生物学的分析の調査拡大
  • サンプル調製における品質管理ツールの使用
  • 希少疾患の治療法を特定するための共同イニシアチブ
• 市場抑制要因
  • DNA-RNAサンプル調製に伴う高コスト
• 市場機会
  • ウェアラブルデバイスや人工知能などのデジタル技術の採用
  • RNA干渉（RNAi）による科学的研究の出現
• 市場の課題
  • RNAサンプル採取における不確実性

ポーターの5つの力：DNA-RNAサンプル調製市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：DNA-RNAサンプル調製市場における外部からの影響の把握

外部マクロ環境要因は、DNA-RNAサンプル調製市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析DNA-RNAサンプル調製市場における競合情勢の把握

DNA-RNAサンプル調製市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスDNA-RNAサンプル調製市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、DNA-RNAサンプル調製市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨DNA-RNAサンプル調製市場における成功への道筋を描く

DNA-RNAサンプル調製市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 分子生物学分析の調査の発展
    • サンプル調製における品質管理ツールの使用
    • 希少疾患の治療法を見つけるための共同イニシアチブ
  • 抑制要因
    • DNA-RNAサンプルの準備に伴う高コスト
  • 機会
    • ウェアラブルデバイスや人工知能などのデジタル技術の導入
    • RNA干渉（RNAi）という形での科学的調査の出現
  • 課題
    • RNAサンプル収集における不確実性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 DNA-RNAサンプル調製市場：タイプ別

• キット
• 試薬・消耗品
• ワークステーション

第7章 DNA-RNAサンプル調製市場：用途別

• 臨床試験
• 診断検査
• 調査アプリケーション

第8章 DNA-RNAサンプル調製市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 診断センター
• 法医学研究所
• 病院

第9章 南北アメリカのDNA-RNAサンプル調製市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のDNA-RNAサンプル調製市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのDNA-RNAサンプル調製市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Arcis Biotechnology Ltd.
• Becton, Dickinson, and Company
• Bio-Rad Laboratories Inc.
• Biomeme, Inc.
• Boster Biological Technology
• Danaher Corporation
• F. Hoffmann-La Roche
• Hudson Robotics, Inc.
• Illumina, Inc.
• Merck KGaA
• PerkinElmer, Inc.
• Qiagen N.V.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. DNA-RNA SAMPLE PREPARATION MARKET RESEARCH PROCESS
• FIGURE 2. DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DNA-RNA SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DNA-RNA SAMPLE PREPARATION MARKET DYNAMICS
• TABLE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY WORKSTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

The DNA-RNA Sample Preparation Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.22 billion in 2024, and is projected to grow at a CAGR of 8.52%, to USD 3.64 billion by 2030.

DNA-RNA sample preparation is an integral component in molecular biology and genetic analysis, providing the foundational material necessary for various applications such as diagnostics, therapeutics development, and forensic analysis. The necessity of efficient and accurate sample preparation is underscored by the urgent need for reliable data in areas like disease detection, genetic research, and personalized medicine. The application spectrum is vast, spanning academic research, clinical diagnostics, biotechnology, and pharmaceutical development. Key end-users include research laboratories, diagnostic centers, and biotechnology companies. The market is heavily influenced by technological advancements in sample preparation techniques, increasing investment in genetic research, and the rising prevalence of genetic disorders necessitating advanced testing methodologies. Innovations, such as automated and high-throughput sample preparation systems, present significant opportunities by reducing error rates and enhancing processing speeds. The growth of genomic research initiatives further bolsters market expansion. However, challenges such as high costs associated with advanced preparation kits, stringent regulatory requirements, and the need for specialized skills can hinder growth. Limitations also arise from the variability in sample quality, which can affect downstream analysis. To overcome these hurdles, businesses should focus on developing cost-effective and simplified protocols that maintain high sample integrity and reliability. Areas ripe for innovation include miniaturization of preparation systems, integration with digital tools for data management, and the development of universal kits that can handle a variety of sample types. The market remains dynamic, characterized by rapid technological advancements and increasing competition. Companies must stay agile, focusing on innovation, strategic partnerships, and engagement with regulatory bodies to navigate market complexities effectively. By aligning product development with the growing trends in personalized medicine and telemedicine, businesses can capture emerging opportunities and sustain growth in this evolving industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA-RNA Sample Preparation Market

The DNA-RNA Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing research in molecular biology analysis
  • Use of quality control tools under the sample preparation
  • Collaborative initiatives to identify therapies for rare illnesses
• Market Restraints
  • High cost affiliated with DNA-RNA sample preparations
• Market Opportunities
  • Adoption of digital technology such as wearable devices and artificial intelligence
  • Emergence of scientific investigation in the form of RNA interference (RNAi)
• Market Challenges
  • Uncertainty in RNA samples collection

Porter's Five Forces: A Strategic Tool for Navigating the DNA-RNA Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA-RNA Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA-RNA Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA-RNA Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA-RNA Sample Preparation Market

A detailed market share analysis in the DNA-RNA Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA-RNA Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA-RNA Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA-RNA Sample Preparation Market

A strategic analysis of the DNA-RNA Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA-RNA Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Arcis Biotechnology Ltd., Becton, Dickinson, and Company, Bio-Rad Laboratories Inc., Biomeme, Inc., Boster Biological Technology, Danaher Corporation, F. Hoffmann-La Roche, Hudson Robotics, Inc., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Qiagen N.V., Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA-RNA Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Kits, Reagents & Consumables, and Workstation.
• Based on Application, market is studied across Clinical Testing, Diagnostic Testing, and Research Application.
• Based on End-User, market is studied across Academic & Research Institute, Contract Research Organization, Diagnostic Centers, Forensic Labs, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing research in molecular biology analysis
    • 5.1.1.2. Use of quality control tools under the sample preparation
    • 5.1.1.3. Collaborative initiatives to identify therapies for rare illnesses
  • 5.1.2. Restraints
    • 5.1.2.1. High cost affiliated with DNA-RNA sample preparations
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of digital technology such as wearable devices and artificial intelligence
    • 5.1.3.2. Emergence of scientific investigation in the form of RNA interference (RNAi)
  • 5.1.4. Challenges
    • 5.1.4.1. Uncertainty in RNA samples collection
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA-RNA Sample Preparation Market, by Type

• 6.1. Introduction
• 6.2. Kits
• 6.3. Reagents & Consumables
• 6.4. Workstation

7. DNA-RNA Sample Preparation Market, by Application

• 7.1. Introduction
• 7.2. Clinical Testing
• 7.3. Diagnostic Testing
• 7.4. Research Application

8. DNA-RNA Sample Preparation Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institute
• 8.3. Contract Research Organization
• 8.4. Diagnostic Centers
• 8.5. Forensic Labs
• 8.6. Hospitals

9. Americas DNA-RNA Sample Preparation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific DNA-RNA Sample Preparation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa DNA-RNA Sample Preparation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Arcis Biotechnology Ltd.
• 3. Becton, Dickinson, and Company
• 4. Bio-Rad Laboratories Inc.
• 5. Biomeme, Inc.
• 6. Boster Biological Technology
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche
• 9. Hudson Robotics, Inc.
• 10. Illumina, Inc.
• 11. Merck KGaA
• 12. PerkinElmer, Inc.
• 13. Qiagen N.V.
• 14. Siemens Healthcare GmbH
• 15. Thermo Fisher Scientific, Inc.